Description of Collaborative Activity: |
The Interagency Clinical Outcome Assessments Working Group (ICOA WG) works to foster the development, evaluation, and qualification of Clinical Outcomes Assessments (COAs) for use in both medical product development and clinical research; leveraging the unique strengths, knowledge, and resources at both the Food and Drug Administration (FDA) and the NIH. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
CC, NCI, NEI, NHLBI, NIA, NIAMS, NICHD, NIDDK, NIMH, NINDS, OD/DPCPSI/ODP, OD/DPCPSI/ORWH |
